Skip to content
Home/Companies/Pharma/Generis
Generis

Generis

Pharma·Portugal·Exited 2017·Held 8yr
Entry
2009
Hold
8yr
Exit
2017

Who owns Generis?

Generis was owned by Magnum Capital through Magnum Capital I (2007 vintage) from 2009 to 2017, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-03

Magnum Capital
Investor
Magnum Capital
Magnum Capital I · 2007 · Buyout

Key facts

HQPortugal
SectorPharma
StatusAcquired
Websitewww.generis.pt
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2017

More from Magnum Capital I

Other portfolio companies in the same fund.

NACE Schools
Exited 2017
EducationSpain· 2014
to
Iberchem
Iberchem
Exited 2017
IndustrialsSpain· 2013
to
Geriatros
Exited 2015
HealthcareSpain· 2012
to
Teknon
Exited 2013
HealthcareSpain· 2010
to
Grupo Vendap
Exited 2022
Business ServicesSpain· 2008
to
Iberwind
Exited 2015
EnergyPortugal· 2008
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Generis

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Generis?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Generis.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue